Instuitional Investor - Arch Venture Corp

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Beam Therapeutics Inc.	BEAM	4,540,132	$77,227,645	25.82%
2.	Vir Biotechnology Inc.	VIR	12,916,663	$65,099,982	21.76%
3.	Maze Therapeutics Inc.		4,120,053	$50,594,251	16.91%
4.	Rapport Therapeutics Inc.		3,728,738	$42,433,038	14.19%
5.	Verve Therapeutics Inc.	VERV	2,008,809	$22,558,925	7.54%